Breast Cancer Imaging: Current Trends and Future Direction (2nd Edition)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: 30 April 2025
Special Issue Editor
Interests: nuclear medicine; image-based diagnostics; SPECT; SPECT/CT; PET/CT; molecular breast imaging; oncology (breast cancer, lung cancer, thyroid cancer, neuroendocrine tumors, and prostate cancer); radiomics; neurodegenerative disorders; radiometabolic therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is a continuation of our previous Special Issue, “Breast Cancer Imaging: Current Trends and Future Direction” (https://www.mdpi.com/journal/cancers/special_issues/BCICTFD).
Imaging plays a key role in the management of breast cancer patients, from screening and initial diagnosis to staging, response to therapy assessment, restaging, and recurrent disease detection.
At present, in addition to routine conventional morphological imaging techniques such as mammography, ultrasound, and computed tomography, more advanced imaging procedures are increasingly used.
These latter include MRI, molecular breast imaging, PET/CT, and the newest PET/MRI, which also provide functional information and quantitative parameters on tumor metabolism and biology, adding diagnostic and prognostic data.
More recently, potential benefits for breast cancer management seem to emerge from artificial intelligence (AI), machine learning (ML), and imaging-derived radiomics.
In this Special Issue, ”Breast Cancer Imaging: Current Trends and Future Direction (2nd Edition),” we encourage researchers to submit original papers, review articles, brief communications, or comments on the current morphological and functional diagnostic imaging procedures adopted in the management of breast cancer patients. Papers that suggest novel approaches, such as AI, ML, and radiomics, are also welcome.
Prof. Dr. Angela Spanu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- mammography
- ultrasound
- magnetic resonance imaging—MRI
- molecular breast imaging
- PET/CT
- PET/MRI
- artificial intelligence
- machine learning
- radiomics
